These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 7647643)

  • 1. Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries.
    Aaby P; Samb B; Simondon F; Seck AM; Knudsen K; Whittle H
    BMJ; 1995 Aug; 311(7003):481-5. PubMed ID: 7647643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A non-specific, beneficial effect of measles vaccination. Analysis of mortality studies from developing countries].
    Aaby MP; Samb B; Simondon F; Seck AM; Knudsen KM; Whittle H
    Ugeskr Laeger; 1996 Oct; 158(42):5944-8. PubMed ID: 8928283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Child mortality following standard, medium or high titre measles immunization in West Africa.
    Knudsen KM; Aaby P; Whittle H; Rowe M; Samb B; Simondon F; Sterne J; Fine P
    Int J Epidemiol; 1996 Jun; 25(3):665-73. PubMed ID: 8671571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: reanalysis of West African studies.
    Aaby P; Jensen H; Samb B; Cisse B; Sodemann M; Jakobsen M; Poulsen A; Rodrigues A; Lisse IM; Simondon F; Whittle H
    Lancet; 2003 Jun; 361(9376):2183-8. PubMed ID: 12842371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced childhood mortality after standard measles vaccination at 4-8 months compared with 9-11 months of age.
    Aaby P; Andersen M; Sodemann M; Jakobsen M; Gomes J; Fernandes M
    BMJ; 1993 Nov; 307(6915):1308-11. PubMed ID: 8257884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routine vaccinations associated with divergent effects on female and male mortality at the paediatric ward in Bissau, Guinea-Bissau.
    Veirum JE; Sodemann M; Biai S; Jakobsen M; Garly ML; Hedegaard K; Jensen H; Aaby P
    Vaccine; 2005 Jan; 23(9):1197-204. PubMed ID: 15629363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanded programme on immunization (EPI). Safety of high titre measles vaccines.
    Wkly Epidemiol Rec; 1992 Nov; 67(48):357-61. PubMed ID: 1449986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Child mortality after high-titre measles vaccines: prospective study in Senegal.
    Garenne M; Leroy O; Beau JP; Sene I
    Lancet; 1991 Oct; 338(8772):903-7. PubMed ID: 1681265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa.
    Kristensen I; Aaby P; Jensen H
    BMJ; 2000 Dec; 321(7274):1435-8. PubMed ID: 11110734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of vaccine efficacy and mortality during routine use of high-titre Edmonston-Zagreb and Schwarz standard measles vaccines in rural Senegal.
    Aaby P; Samb B; Simondon F; Knudsen K; Seck AM; Bennett J; Markowitz L; Whittle H
    Trans R Soc Trop Med Hyg; 1996; 90(3):326-30. PubMed ID: 8758096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Routine vaccinations and child survival in a war situation with high mortality: effect of gender.
    Aaby P; Jensen H; Garly ML; Balé C; Martins C; Lisse I
    Vaccine; 2002 Nov; 21(1-2):15-20. PubMed ID: 12443658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five year follow-up of morbidity and mortality among recipients of high-titre measles vaccines in Senegal.
    Aaby P; Samb B; Simondon F; Knudsen K; Seck AM; Bennett J; Markowitz L; Whittle H
    Vaccine; 1996 Feb; 14(3):226-9. PubMed ID: 8920704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased female-male mortality ratio associated with inactivated polio and diphtheria-tetanus-pertussis vaccines: Observations from vaccination trials in Guinea-Bissau.
    Aaby P; Garly ML; Nielsen J; Ravn H; Martins C; Balé C; Rodrigues A; Benn CS; Lisse IM
    Pediatr Infect Dis J; 2007 Mar; 26(3):247-52. PubMed ID: 17484223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caution--mortality ratios ahead.
    Cutts FT; Fine PE
    Lancet; 2003 Jun; 361(9376):2169-70. PubMed ID: 12842364
    [No Abstract]   [Full Text] [Related]  

  • 15. Early two-dose measles vaccination schedule in Guinea-Bissau: good protection and coverage in infancy.
    Garly ML; Martins CL; Balé C; da Costa F; Dias F; Whittle H; Aaby P
    Int J Epidemiol; 1999 Apr; 28(2):347-52. PubMed ID: 10342702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanded programme on immunization. Safety and efficacy of high titre measles vaccine at 6 months of age.
    Wkly Epidemiol Rec; 1991 Aug; 66(34):249-51. PubMed ID: 1911167
    [No Abstract]   [Full Text] [Related]  

  • 17. Co-administration of live measles and yellow fever vaccines and inactivated pentavalent vaccines is associated with increased mortality compared with measles and yellow fever vaccines only. An observational study from Guinea-Bissau.
    Fisker AB; Ravn H; Rodrigues A; Østergaard MD; Bale C; Benn CS; Aaby P
    Vaccine; 2014 Jan; 32(5):598-605. PubMed ID: 24325827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The survival benefit of measles immunization may not be explained entirely by the prevention of measles disease: a community study from rural Bangladesh.
    Aaby P; Bhuiya A; Nahar L; Knudsen K; de Francisco A; Strong M
    Int J Epidemiol; 2003 Feb; 32(1):106-16. PubMed ID: 12690020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survival in trial of medium-titre Edmonston-Zagreb measles vaccine in Guinea-Bissau: five-year follow-up.
    Aaby P; Lisse IM; Whittle H; Knudsen K; Thaarup J; Poulsen A; Sodemann M; Jakobsen M; Brink L; Gansted U
    Epidemiol Infect; 1994 Apr; 112(2):413-20. PubMed ID: 8150016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compliance with diphtheria, tetanus, and pertussis immunisation in Bangladesh: factors identifying high risk groups.
    Zeitlyn S; Rahman AK; Nielsen BH; Gomes M; Kofoed PE; Mahalanabis D
    BMJ; 1992 Mar; 304(6827):606-9. PubMed ID: 1559089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.